Objective-Aortic pathologies exhibit sexual dimorphism, with aneurysms in both the thoracic and abdominal aorta (ie, abdominal aortic aneurysm [AAA]) exhibiting higher male prevalence. Women have lower prevalence of aneurysms, but when they occur, aneurysms progress rapidly. To define mechanisms for these sex differences, we determined the role of sex chromosome complement and testosterone on the location and progression of angiotensin II (AngII)-induced aortic pathologies. Approach and Results-We used transgenic male mice expressing Sry (sex-determining region Y) on an autosome to create Ldlr (low-density lipoprotein receptor)-deficient male mice with an XY or XX sex chromosome complement. Transcriptional profiling was performed on abdominal aortas from XY or XX males, demonstrating 1746 genes influenced by sex chromosomes or sex hormones. Males (XY or XX) were either sham-operated or orchiectomized before AngII infusions. Diffuse aortic aneurysm pathology developed in XY AngII-infused males, whereas XX males developed focal AAAs. Castration reduced all AngII-induced aortic pathologies in XY and XX males. Thoracic aortas from AngII-infused XY males exhibited adventitial thickening that was not present in XX males. We infused male XY and XX mice with either saline or AngII and quantified mRNA abundance of key genes in both thoracic and abdominal aortas. Regional differences in mRNA abundance existed before AngII infusions, which were differentially influenced by AngII between genotypes. Prolonged AngII infusions resulted in aortic wall thickening of AAAs from XY males, whereas XX males had dilated focal AAAs. Conclusions-An XY sex chromosome complement mediates diffuse aortic pathology, whereas an XX sex chromosome complement contributes to focal AngII-induced AAAs. Visual Overview-An online visual overview is available for this article.
A ortic vascular diseases are life-threatening conditions that are not typically symptomatic, which is of concern because ruptures result in high morbidity and mortality. Among the various risk factors that have been identified for aortic vascular diseases, male sex has emerged as a positive risk factor for aneurysmal disease in the ascending aorta 1 and distal thoracic aorta (thoracic aortic aneurysm [TAA]) 2 and for abdominal aortic aneurysms (AAAs). [3] [4] [5] [6] [7] [8] Recent studies analyzing patients within the GenTAC registry (Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions) demonstrated that adult males with Marfan syndrome were more likely than females to have aortic root dilatation (by 8%) and aortic regurgitation (by 19%), and the prevalence of previous aortic dissection tended to be higher in males (by 7%). 9 Similarly, TAAs are also more prevalent in men. 10 Male sex is considered one of the largest nonmodifiable risk factors for AAAs, with estimates ranging from a 2-to 10-fold greater prevalence in men compared with women. 6, 8, 11, 12 A higher prevalence of aortic vascular diseases in men is not restricted to aneurysms because the incidence of acute aortic dissection is also higher in men than in women. [13] [14] [15] Despite a uniformly lower incidence of various forms of aortic vascular diseases in women compared with men, paradoxically, women exhibit more rapid growth rates of both TAAs and AAAs than men, and aneurysms rupture at smaller sizes. 2, [16] [17] [18] [19] [20] [21] [22] Mechanisms for these sex differences in aortic vascular disease development versus progressive growth have not been defined.
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Similar to humans, studies from our laboratory demonstrated that AAAs induced by infusion of angiotensin II (AngII) to hypercholesterolemic mice exhibit a high level of sexual dimorphism, with a 4-fold higher AAA prevalence in male compared with female mice. 23 Testosterone was identified as a primary contributor to higher AAA prevalence in AngII-infused male mice. [23] [24] [25] [26] Moreover, administration of testosterone to neonatal female Ldlr (low-density lipoprotein receptor)-deficient mice infused with AngII augmented development of aneurysms in the ascending and abdominal aorta. 27 Adult female mice exposed to testosterone as neonates maintained a high susceptibility to AngII-induced aortic vascular diseases. 27 In contrast, AAA incidence was markedly reduced when adult male mice were castrated. 23 These results suggest that although testosterone is a primary mediator of sexual dimorphism of experimental aortic vascular diseases, other differences between males and females may contribute to sexual dimorphism of vascular disease development and severity.
In addition to sex hormones, recent studies demonstrated that an XY sex chromosome complement was sufficient to promote a high level of AAA susceptibility in female Ldlr −/− mice infused with AngII. 28 Moreover, XY females exhibited increased aneurysm rupture, which rose to 73% when females were exposed to dihydrotestosterone to mimic an adult male milieu. These results suggest that sex chromosome complement also has profound effects on the vasculature, which is of interest because women with Turner syndrome (monosomy X) exhibit an 100-fold increased risk of aortic dissection. 29 The purpose of this study was to define the relative role of sex hormones versus sex chromosome complement on the location and characteristics of aortic vascular diseases after AngII infusions. The 4-core genotype murine model was used to assess the relative role of sex hormones versus sex chromosome complement on the formation and progression of AngII-induced AAAs. This model produces mice in which the sex chromosome complement (XX versus XY) is varied independently of gonadal sex (testes versus ovaries). The 4-core genotype murine model was created from a natural mutation of the Sry (sex-determining region Y) gene (testis determining gene) on the Y chromosome of mice (XY − ), where an Sry transgene was inserted onto an autosome for testes formation and fertility (XY
−Sry
). 30 Breeding of XY −Sry male mice to XX females produces 4-core genotype murine: XX and XY males, XX and XY females. Because testosterone promotes AngII-induced aortic aneurysms and AAAs in male mice, 23, 24 we performed studies on male Ldlr −/− mice with an XY and an XX sex chromosome complement in the presence or absence of male sex hormones Because men experience a higher prevalence of aortic aneurysms, TAAs, and AAAs than women, we hypothesize that testosterone and an XY sex chromosome complement promote vascular disease along the length of the aorta in male mice infused with AngII.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Testosterone and Sex Chromosome Complement Influenced Abdominal Aortic Gene Expression Patterns and Aortic Stiffness
We demonstrated recently that an XY sex chromosome complement promoted expression of inflammatory gene pathways in abdominal aortas from female Ldlr −/− mice. 28 Because previous studies focused on abdominal aortas of XX and XY females, in this study, we used RNA extracted from abdominal aortas of XY and XX male mice (noninfused) that were gonadally intact (sham-operated) or orchiectomized for Affymetrix Mouse Transcriptome Assay 1.0 analysis. A total of 1746 genes exhibited highly significant differences (2-way ANOVA, P<0.01; Figure 1A ; Table I in the online-only Data Supplement). There was a significant main effect of sex chromosome (450 genes; false discovery rate [FDR]=0.32), castration (799 genes, orchiectomized versus sham; FDR=0.14), and an interaction between sex chromosome and castration (708 genes; FDR=0.24; Figure 1) . A frequency histogram of the number of genes (y axis) found at different P value cutoffs (x axis), with chance depicted by the dashed line, illustrates the number of genes influenced by sex chromosome complement, castration, or an interaction between sex chromosomes and sex hormones at different P values (Figure 1 ). Volcano plots of the chromosome effect with highly stringent cutoffs (>2-fold change, P≤0.01) demonstrated that, as expected, the expression of genes on sex chromosomes was influenced strongly (Figure 1 ). Using this level of stringency, 5 genes (Xist, Arntl, Npas2, Arhgap20, and Ighv14-1) were increased significantly in abdominal aortas of sham-operated XX compared with XY males (Figure 1 ; Table III in the online-only Data Supplement). In contrast, 51 genes were increased significantly in abdominal aortas of sham-operated XY compared with XX males (Table  III in Figure II in the online-only Data Supplement). Biological pathway analysis revealed several expression patterns, potentially related to aortic vascular diseases, that were increased in abdominal aortas of XY compared with XX males (immune response and acute inflammatory response), whereas other pathways were increased in abdominal aortas of XX compared with XY males (eg, DNA binding and regulation of cell proliferation; Figure 1 ; Table IV in the online-only Data Supplement).
To determine whether differences in gene expression patterns (eg, extracellular matrix, Figure 1 ) between aortas of XY and XX males influenced aortic function, we quantified pulse wave velocity as an index of aortic stiffness in noninfused XY and XX Ldlr −/− males. Aortas from XY males exhibited significant increases in pulse wave velocity compared with XX males ( Figure III in the online-only Data Supplement).
Aortic Aneurysmal Disease Was Diffuse in XY Males and Localized in XX Males
At study end point, body weights of castrated (orchiectomized) male mice infused with AngII were decreased significantly compared with sham-operated controls, regardless of genotype (P<0.05; Aortas from XY sham-operated AngII-infused males exhibited diffuse disease that typically extended from the aortic arch to the suprarenal aorta ( Figure 2A , top left). In contrast, aortas from XX AngII-infused males exhibited aortic pathology that was generally restricted to the suprarenal portion of the abdominal aorta ( Figure 2A , top right). As an index of the extent of aortic pathology, aorta weights were increased significantly in XY compared with XX males, with aortic weights decreased by castration in both genotypes ( Figure 2B ; P<0.05). The area of the aortic arch was increased significantly in XY compared with XX AngII-infused sham-operated males ( Figure 2C ; P<0.05), with reductions in arch areas after castration of XY males. The incidence of aneurysms in the aortic arch or thoracic aorta (TAAs) was markedly higher in XY (44%) compared with XX (8%) AngII-infused males ( Figure 2D ; P<0.05). This difference was abolished by castration, which resulted in almost complete ablation of AngIIinduced TAAs in both genotypes.
In contrast to diffuse aortic disease of XY males infused with AngII, XX males exhibited focal aortic disease within the suprarenal portion of the abdominal aorta, with significant increases in external AAA diameters that were abolished by castration ( Figure 3A ; P<0.05). Similarly, abdominal aortic lumen diameters were increased significantly in XX compared with XY sham-operated males infused with AngII (day 28, Figure 3B ; P<0.05). The high incidence of AAAs was not significantly different between XX and XY AngII-infused males ( Figure 3C ; P>0.05), and castration significantly decreased AAA incidences of both genotypes ( Figure 3C ; P<0.05). Larger AAAs of XX males were associated with slight but insignificant increases in aneurysmal rupture ( Figure 3D ; P>0.05), which were also reduced by castration of XX males. Because XY but not XX males exhibited considerable aortic pathology in the thoracic aorta, we characterized morphology of tissue sections prepared from thoracic aortas of XY and XX males infused with AngII. Thoracic aorta tissue sections from XY AngII-infused males exhibited pronounced thickening of the adventitia, which was not evident in thoracic aortas of XX males ( Figure 4A and 4B). Adventitial thickening of thoracic aortas from XY males was abolished by castration ( Figure 4A and 4B ). In contrast, medial diameters were not significantly different between XY and XX males and were not influenced by castration (Figure 4A and 4C; P>0.05).
Aortic Genes Related to AAA Development Exhibited Region-Specific and AngII-Induced Differences in Abundance
Initial studies defined gene expression patterns in abdominal aortas from noninfused male XY and XX mice (Figure 1 ). To determine whether differences in aortic disease development between XY and XX male mice are associated with regional differences in aortic gene expression and whether AngII regulates aortic genes in a region-specific manner, we contrasted effects of short-term (1 day) infusions of saline versus AngII on abundance of genes within the thoracic versus abdominal aortas of male XY and XX Ldlr −/− mice. We chose short-term AngII infusions to limit the extent of overt aneurysm pathology between genotypes. Abundance of angiotensin-converting enzyme, collagen 1a1, and Thbs1 (thrombospondin 1) mRNAs were increased significantly in abdominal compared with thoracic aortas of XX but not XY saline-infused male mice (Figure 5A through 5D; P<0.05) . Moreover, abdominal aortas of saline-infused XX males exhibited significantly increased mRNA abundance of angiotensin-converting enzyme, collagen 1a1, and Thbs1 compared with abdominal aortas of saline-infused XY males ( Figure 1A, 1C, and 1D ; P<0.05). Infusion of AngII resulted in significant elevations in mRNA abundance of MMP2 (matrix metalloproteinase 2), collagen 1a1, and Thbs1 in thoracic but not abdominal aortas of XY male mice compared with XY saline-infused controls (Figure 5B through 5D; P<0.05) . In contrast, abdominal aortas of XX males did not respond to AngII with increased expression of MMP2 or Thbs1. However, mRNA abundance of collagen 1a1 was decreased significantly by AngII in abdominal aortas of XX males. As a result, after AngII infusions, marked regional differences in expression levels of MMP2, collagen 1a1, and Thbs1 were evident, with increased expression levels in thoracic compared with abdominal aortas of XY and XX male mice (Figure 5B through 5D; P<0.05) . The magnitude of AngII-induced changes in the regional expression levels of these genes were more pronounced in XY than in XX male mice.
Regional Differences in AngII-Induced Aortic Vascular Diseases Between XY and XX Males Persisted With Aneurysm Progression
Despite a lower prevalence of TAA and AAA development in women compared with men, previous studies demonstrated that aneurysm growth rates are more aggressive in women, and aneurysms may rupture at smaller sizes.
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Therefore, we examined progression of aortic vascular diseases in response to 3 months of prolonged AngII infusions in XY and XX males. Increased abdominal aortic lumen diameters of XX males persisted with prolonged AngII infusions ( Figure 6A; P<0.05) . Surprisingly, dilated abdominal aortas of XX males were not associated with significantly larger AAA diameters at study end point ( Figure 6B ; P>0.05). These results suggest divergent aneurysm remodeling between genotypes. Similar to 28-day AngII infusions, XY males infused with AngII for 3 months exhibited diffuse aortic disease ( Figure 6C ), resulting in significant increases in aorta weight ( Figure 6D ; P<0.05) and incidence of TAAs compared with XX males (Figure 6E ; P<0.05).
Because maximal AAA diameters were not different between XY and XX males but aneurysms of XX males were more dilated, we performed ex vivo ultrasound analysis of AAA 3-dimensional structures after prolonged AngII infusions ( Figure 
Discussion
The key novel findings of this study are as follows: (1) male sex hormones, coupled with an XY sex chromosome complement, result in development of diffuse aortic disease associated with adventitial thickening in response to AngII infusions. (2) In contrast, an XX sex chromosome complement in phenotypic male mice results in focal aneurysmal disease within the suprarenal abdominal aorta. (3) These regional differences in aortic vascular disease development are associated with differences in abundance of genes implicated in aneurysmal disease between thoracic versus abdominal aortas of XY and XX male mice. (4) Short-term infusion of AngII superimposes pronounced regional differences in aortic gene It is well established that male sex is a significant nonmodifiable risk factor for development of AAAs, with men exhibiting a 2-to 10-fold higher prevalence than women. 6, 8, 11, 12 Recent results, performed on a large population of well-characterized patients with Marfan syndrome, also exhibited a higher prevalence of aortic root dilatation and regurgitation in men compared with women. 1 Moreover, using data from the Swedish national healthcare registers from 1987 to 2002, the incidence of TAA was 52% in men compared with 28% in women. 10 Collectively, these studies indicate that men exhibit a higher prevalence of vascular disease localized to different regions of the aorta compared with women. A variety of mechanisms for these differences have been proposed, ranging from influences of sex hormones and their receptors, 32 differences in aortic stiffness, 33 hemodynamic influences, and basic differences in aortic size between sexes. [34] [35] [36] [37] Of interest, sex chromosome abnormalities, such as Turner syndrome (monosomy X), are associated with a higher risk of aortic dissection, 29 another aortic vascular disease that exhibits higher prevalence in men than women. 38 Recent studies from our laboratory demonstrated that an XY sex chromosome complement, when inserted in phenotypic females with low circulating testosterone, was sufficient to increase the incidence and severity of AngII-induced AAAs. 28 We also noted that exposure of XY females to dihydrotestosterone, to mimic a male-like milieu, resulted in a striking level of aneurysm rupture. 28 In this study, we used male mice with an XY or XX sex chromosome complement because males experience testosterone exposures throughout life, and testosterone has been demonstrated to increase AngII-induced AAAs in male or female mice. 23, 24, 27 Our results demonstrate that testosterone, through a sex chromosome-dependent (XY) mechanism, promotes the presence of diffuse aortic vascular disease in male mice infused with AngII. In contrast, aortas from XX males exhibit focal aortic pathology manifest within the suprarenal region of the abdominal aorta, as has been typically described for AngII-induced AAAs that occur in females. 39 These striking differences in regional location of AngII-induced aortic pathology were both sex chromosome and sex hormone mediated. Several potential mechanisms have been suggested to contribute to sex differences in aortic vascular disease development. 40 In this study, gene expression analysis exhibited 1746 genes that were differentially expressed in abdominal aortas of noninfused XY and XX males according to sex hormone (eg, influenced by castration) and sex chromosome complement or by an interaction between these factors. Pathway analysis of gene array data identified genes related to extracellular matrix, acute inflammatory response, regulation of cell proliferation, and the immune response may relate to differences in AAA susceptibility between males and females. Of the aortic genes exhibiting pronounced differences based on sex chromosome complement, Xist, the RNA gene within the X chromosome that is the effector of the X-inactivation process, confirms the validity of sex chromosome manipulation in XX males. Arntl (BMAL1) and Npas2, genes enriched in aortas from XX compared with XY males, are genes expressing proteins that are core components of the circadian clock apparatus. To our knowledge, there is minimal information related to influences of circadian rhythm on AAA formation and rupture. Abdominal aortas from XY males had higher mRNA abundance of Cyp2e1 (a member of the cytochrome p450 enzyme family) and kidney androgen-regulated protein (Kap) compared with XX males. It is unclear whether these differences in abdominal aortic gene expression between XY and XX males are related to aneurysm outcomes of the current study. An intriguing difference between XY and XX males infused with AngII was the large adventitial thickening that occurred in the thoracic aorta of XY but not XX males. Increased adventitial thickening in response to AngII infusions in thoracic aortas may have contributed to the observed augmented aortic stiffening of XY males. 41 Because blood pressures were increased significantly in XY compared with XX males infused with AngII, it is possible that hemodynamic differences contributed to these divergent morphological responses and susceptibility to AngII-induced TAAs between genotypes. However, blood pressure was similar in AngII-infused sham and castrated males, even though TAA incidence was markedly reduced by castration. These results suggest that blood pressure may not be the primary contributor to the development of diffuse aortic vascular pathologies of XY males. Previous investigators demonstrated a large number of genes (1475) that are differentially expressed in the ascending versus descending aortas of female mice. 42 These differences were ascribed to developmental origins of cells within distinct regions of the aorta. Specifically, smooth muscle cells of the ascending aorta develop from cardiac neural crest and second heart field, 43 and descending aorta cells develop from somites, whereas those of the abdominal aorta are derived from mesodermal origin. 44 These differences have been suggested to contribute to diverging physiological and pathophysiological responses of the aorta, including regulation of the extracellular matrix. 26, 44, 45 Notably, previous studies indicate that cells of mesodermal origin that populate the abdominal aorta express androgen receptors, 46 and recent studies indicate increased expression of androgen receptors in abdominal aortas of patients with an AAA compared with control aorta. 32 In this study, with the exception of collagen 1, XY and XX males exhibited the opposite patterns of gene expression in abdominal versus thoracic aortas, with increased thoracic gene expression in XY males and increased abdominal gene expression in XX males. Notably, infusion of AngII resulted in robust regional differences in expression patterns of several genes with more robust regional differences (eg, higher in thoracic than abdominal) in aortas from XY males exhibiting diffuse disease in response to the peptide. It is unclear whether embryonic origins of vascular wall cells contribute to the observed regional differences in aortic gene expression patterns or the regional responses to AngII.
Despite a lower prevalence of aortic vascular disease in women than in men, women with AAAs or TAAs seem to exhibit more progressive aneurysmal growth, with a propensity to rupture at smaller aneurysm sizes. 2, 21, 22, 35, [47] [48] [49] Previous results from our laboratory demonstrated that castration of male mice with established AngII-induced AAAs resulted in aneurysm remodeling, with thin-walled AAAs of castrated males compared with muscularized aneurysms of intact males. 50 Results of the current study agree with previous findings, in that AAAs of XY males had large wall volumes as they continued to grow. In addition, the diffuse nature of aortic vascular pathology of XY males persisted with prolonged AngII infusions. In contrast, XX males exhibited dilated thin-walled AAAs with prolonged AngII infusions, suggesting an increased propensity of weakened aortas to rupture. These results indicate that sex chromosome-mediated influences on aortic vascular biology may contribute to differences in the progression of aortic vascular disease between sexes.
A limitation of the model used in these studies is that it does not define whether the observed phenotype results from genes residing on the Y or second X chromosome (that escape X inactivation). Moreover, XX males that are derived from this breeding strategy are infertile and have small testes because they lack the Y chromosome genes that are responsible for spermatogenesis. However, because XX mice have serum testosterone concentrations that are not significantly different from male XY mice (Supplemental Table V) , it is unlikely that these differences influenced experimental findings.
In conclusion, this study demonstrates that sex chromosome complement, coupled with sex hormones (eg, testosterone), modulate the region-specific development of aortic pathology in response to AngII. An XY sex chromosome complement in males resulted in diffuse aneurysmal disease along the aorta, whereas a male XX sex chromosome complement mediated focal abdominal aortic aneurysmal disease. These regional differences in aortic vascular disease according to sex chromosome complement were dependent on the presence of male sex hormones. Regional differences in expression levels of genes implicated in aneurysm development between thoracic versus abdominal aortas from XY and XX males may contribute to divergent aneurysm susceptibility and regional location of aortic pathology between sexes in response to AngII. Finally, aneurysm progression and remodeling were differentially regulated by sex chromosome complement, with XX males exhibiting thin-walled AAAs and XY males exhibiting thickened AAAs and diffuse aortic disease from prolonged AngII infusions. These studies suggest that sex differences between men and women in development and progression of aortic vascular diseases may arise from the complex interplay between sex hormones and sex chromosome complement in defining regional aortic gene expression, diffuse versus focal aortic pathology, and differential aneurysm remodeling of aortic vascular diseases.
